CHL D75 Pill - blue & white capsule/oblong, 16mm
Pill with imprint CHL D75 is Blue & White, Capsule/Oblong and has been identified as Doxycycline Hyclate 50 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Doxycycline is used in the treatment of Actinomycosis; Acne; Amebiasis; Anthrax; Gonococcal Infection, Uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CHL D75


Doxycycline Hyclate
- Imprint
- CHL D75
- Strength
- 50 mg
- Color
- Blue & White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1358
- Inactive Ingredients
-
alcohol,
ammonia,
lactose anhydrous,
butyl alcohol,
microcrystalline cellulose,
croscarmellose sodium,
D&C Red No. 28,
FD&C Blue No. 1,
ferrosoferric oxide,
gelatin,
isopropyl alcohol,
magnesium stearate,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
titanium dioxide
Note: Inactive ingredients may vary.
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,635)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.